Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Zio AT ECG Monitoring System

Acumen HPI integrates into intraoperative and critical care workflows by providing real-time, predictive insights into hypotensive events up to 15 minutes in advance, allowing clinicians to proactively manage hemodynamic instability and potentially reduce the duration and severity of intraoperative hypotension. Zio AT integrates into outpatient cardiology workflows as a wearable, long-term continuous ECG monitor for arrhythmia detection, offering comprehensive end-of-wear reports and real-time data transmission via a wireless gateway to a clinician portal, which can lead to changes in treatment strategy.

Acumen HPI software has demonstrated high accuracy in predicting hypotension, with reported sensitivity and specificity of 89% and 90% respectively, and an AUC of 0.95, 10 minutes before an event in surgical patients. Zio AT, utilizing an FDA-cleared deep-learned AI algorithm, has shown superior diagnostic yield for specified arrhythmias compared to shorter monitoring durations, with studies indicating high physician agreement (99%) with end-of-wear reports. While specific sensitivity and specificity for Zio AT across diverse populations are not detailed in the provided snippets, its long-term, continuous monitoring improves arrhythmia detection rates.

Acumen HPI is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, and while it provides valuable hemodynamic data, the depth of direct, automated EHR integration for discrete data flow beyond its platform is not explicitly detailed. Zio AT offers seamless EHR integration, allowing healthcare providers to submit and sign electronic orders, and receive comprehensive end-of-wear reports directly into their EHR systems, including discrete data for over 195 fields, enhancing workflow efficiency and supporting population health management.

For Acumen HPI, Edwards Lifesciences provides a continuum of educational resources and tools, including clinical education, to support clinicians in surgical and critical care settings, suggesting a structured approach to proficiency. For Zio AT, iRhythm offers a dedicated learning platform called iRhythm Academy with expert-guided, on-demand educational content for the entire healthcare team, including tutorials on Zio products and services, to facilitate understanding and informed decision-making.

Edwards Lifesciences provides 24/7 technical support for Acumen HPI, along with customer service for product information and orders, ensuring ongoing assistance for seamless implementation and use. iRhythm offers comprehensive provider support for Zio AT, including customer care for troubleshooting and general inquiries, and emphasizes an end-to-end service that includes advanced AI-assisted analysis and expert review of reports.

The provided information does not explicitly detail additional security measures beyond HIPAA compliance or specific audit trail features for either Acumen HPI or Zio AT. However, iRhythm's EHR integration through Epic's Aura network emphasizes secure transmission of orders and results.

For Acumen HPI, deployment is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, implying that multi-site rollout would likely involve scaling this existing infrastructure. For Zio AT, iRhythm's cloud-based data analytics and clinician portal, coupled with its seamless EHR integration capabilities across major systems, including Epic via the Aura network, suggests a design conducive to scalable population health management and efficient multi-site deployment by centralizing workflows and reducing administrative burden.